Catecholaminergic polymorphic ventricular tachycardia

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Catecholaminergic polymorphic ventricular tach ycardia (CPVT) is an inherited disease character ized by adrenergically mediated polymorphic ventricular tachycardia (VT) leading to syncope and sudden cardiac death. It was initially described by Coumel et al. in 1978.1 A series of cases were reported by the same group in 1995.2 The clinical presentation encompasses exercise- or emotioninduced syncopal events and a distinctive pattern of reproducible, stress-related, bidirectional VT in the absence of both structural heart disease and a prolonged QT interval. Since 2001, molecular genetic studies have reveiled that CPVT results from inherited defects of intracellular calcium handling in cardiac myocytes.3 In this chapter, the current knowledge of CPVT will be reviewed with a focus on the genetics, pathophysiology, and clinical management.

Original languageEnglish
Title of host publicationElectrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention
PublisherSpringer London
Pages536-544
Number of pages9
ISBN (Print)9781846288531
DOIs
Publication statusPublished - 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Catecholaminergic polymorphic ventricular tachycardia'. Together they form a unique fingerprint.

  • Cite this

    Liu, N., Napolitano, C., & Priori, S. G. (2008). Catecholaminergic polymorphic ventricular tachycardia. In Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention (pp. 536-544). Springer London. https://doi.org/10.1007/978-1-84628-854-8_36